Importer of Controlled Substances Application: Cambridge Isotope Laboratories, 51384 [2021-19944]
Download as PDF
<![CDATA[
51384
Federal Register / Vol. 86, No. 176 / Wednesday, September 15, 2021 / Notices
personnel, solely for cybersecurity
purposes. All contract personnel will
sign appropriate nondisclosure
agreements. All non-confidential
written submissions will be available for
public inspection at the Office of the
Secretary and on EDIS.
The Commission vote for this
determination took place on September
9, 2021.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: September 9, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021–19849 Filed 9–14–21; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Antitrust Division
Granting of Requests for Early
Termination of the Waiting Period
Under the Premerger Notification
Rules
Section 7A of the Clayton Act, 15
U.S.C. 18a, as added by Title II of the
Hart-Scott-Rodino Antitrust
Improvements Act of 1976, requires
persons contemplating certain mergers
or acquisitions to give the Federal Trade
Commission and the Assistant Attorney
General advance notice and to wait
designated periods before
consummation of such plans. Section
7A(b)(2) of the Act permits the agencies,
in individual cases, to terminate this
waiting period prior to its expiration
and requires that notice of this action be
published in the Federal Register. The
following transaction was granted early
termination—on the date indicated—of
the waiting period provided by law and
the premerger notification rules. The
listing includes the transaction number
and the parties to the transaction. The
Federal Trade Commission and the
Assistant Attorney General for the
Antitrust Division of the Department of
Justice made the grants. Neither agency
intends to take any action with respect
to this proposed acquisitions during the
applicable waiting period.
EARLY TERMINATION GRANTED
08/26/2021
20212939 ...........................
G
Alight, Inc.; Alight Solutions LLC; Aon plc; Aon Hewitt Health Market Insurance Solutions Inc.
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division, Department of Justice.
[FR Doc. 2021–19943 Filed 9–14–21; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–893]
Importer of Controlled Substances
Application: Cambridge Isotope
Laboratories
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cambridge Isotope
Laboratories has applied to be registered
as an importer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTAL INFORMATION listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 15, 2021. Such
persons may also file a written request
for a hearing on the application on or
before October 15, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:08 Sep 14, 2021
Jkt 253001
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 29, 2021,
Cambridge Isotope Laboratories, 50
Frontage Road, Andover, Massachusetts
01810–5413, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
Controlled substance
Gamma Hydroxybutyric
Acid.
Tetrahydrocannabinols ....
Morphine ..........................
Drug
code
Schedule
2010
I
7370
9300
I
II
The company plans to import the listed
controlled substances for analytical
research. No other activity for this drug
code is authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–19944 Filed 9–14–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act
On September 9, 2021, the U.S.
Department of Justice (DOJ) filed a
Complaint and lodged a proposed
Consent Decree with the United States
District Court for the Eastern District of
Michigan in United States of America
and Michigan Department of
Environment, Great Lakes, and Energy
v. Arbor Hills Energy LLC No. 5:21–cv–
12098.
The proposed Consent Decree
resolves several Clean Air Act and State
law claims against Arbor Hills Energy
LLC (AHE), including for exceedances
of permitted SO2 emissions limits, at
AHE’s landfill gas-to-energy facility in
Northville, Michigan. The AHE facility
converts landfill gas (LFG), which is
generated by decomposition of waste
from an adjacent landfill, into electricity
by burning it as fuel in four gas turbines.
E:\FR\FM\15SEN1.SGM
15SEN1
]]>Agencies
[Federal Register Volume 86, Number 176 (Wednesday, September 15, 2021)]
[Notices]
[Page 51384]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19944]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-893]
Importer of Controlled Substances Application: Cambridge Isotope
Laboratories
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cambridge Isotope Laboratories has applied to be registered as
an importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before October 15,
2021. Such persons may also file a written request for a hearing on the
application on or before October 15, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on July 29, 2021, Cambridge Isotope Laboratories, 50
Frontage Road, Andover, Massachusetts 01810-5413, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............... 2010 I
Tetrahydrocannabinols................... 7370 I
Morphine................................ 9300 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
analytical research. No other activity for this drug code is authorized
for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-19944 Filed 9-14-21; 8:45 am]
BILLING CODE P
